These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 11838628

  • 1. Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.
    Rapaport MH, Endicott J, Clary CM.
    J Clin Psychiatry; 2002 Jan; 63(1):59-65. PubMed ID: 11838628
    [Abstract] [Full Text] [Related]

  • 2. Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.
    Londborg PD, Hegel MT, Goldstein S, Goldstein D, Himmelhoch JM, Maddock R, Patterson WM, Rausch J, Farfel GM.
    J Clin Psychiatry; 2001 May; 62(5):325-31. PubMed ID: 11411812
    [Abstract] [Full Text] [Related]

  • 3. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.
    Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA.
    J Clin Psychiatry; 2000 Feb; 61(2):101-9. PubMed ID: 10732657
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
    Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM.
    JAMA; 2000 Apr 12; 283(14):1837-44. PubMed ID: 10770145
    [Abstract] [Full Text] [Related]

  • 5. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.
    Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM.
    Arch Gen Psychiatry; 2001 May 12; 58(5):485-92. PubMed ID: 11343529
    [Abstract] [Full Text] [Related]

  • 6. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.
    Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH.
    J Clin Psychiatry; 2008 Apr 12; 69(4):520-5. PubMed ID: 18278987
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder.
    Panahi Y, Moghaddam BR, Sahebkar A, Nazari MA, Beiraghdar F, Karami G, Saadat AR.
    Psychol Med; 2011 Oct 12; 41(10):2159-66. PubMed ID: 21349225
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.
    Davidson J, Pearlstein T, Londborg P, Brady KT, Rothbaum B, Bell J, Maddock R, Hegel MT, Farfel G.
    Am J Psychiatry; 2001 Dec 12; 158(12):1974-81. PubMed ID: 11729012
    [Abstract] [Full Text] [Related]

  • 9. Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.
    Kocsis JH, Schatzberg A, Rush AJ, Klein DN, Howland R, Gniwesch L, Davis SM, Harrison W.
    Arch Gen Psychiatry; 2002 Aug 12; 59(8):723-8. PubMed ID: 12150648
    [Abstract] [Full Text] [Related]

  • 10. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
    Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, Pedersen R, Musgnung J.
    Arch Gen Psychiatry; 2006 Oct 12; 63(10):1158-65. PubMed ID: 17015818
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.
    Liebowitz MR, DeMartinis NA, Weihs K, Londborg PD, Smith WT, Chung H, Fayyad R, Clary CM.
    J Clin Psychiatry; 2003 Jul 12; 64(7):785-92. PubMed ID: 12934979
    [Abstract] [Full Text] [Related]

  • 12. Association between serotonin transporter gene promoter-region polymorphism and 4- and 12-week treatment response to sertraline in posttraumatic stress disorder.
    Mushtaq D, Ali A, Margoob MA, Murtaza I, Andrade C.
    J Affect Disord; 2012 Feb 12; 136(3):955-62. PubMed ID: 21962566
    [Abstract] [Full Text] [Related]

  • 13. Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial.
    Robb AS, Cueva JE, Sporn J, Yang R, Vanderburg DG.
    J Child Adolesc Psychopharmacol; 2010 Dec 12; 20(6):463-71. PubMed ID: 21186964
    [Abstract] [Full Text] [Related]

  • 14. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
    Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD.
    J Clin Psychiatry; 2001 Nov 12; 62(11):860-8. PubMed ID: 11775045
    [Abstract] [Full Text] [Related]

  • 15. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.
    Friedman MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM.
    J Clin Psychiatry; 2007 May 12; 68(5):711-20. PubMed ID: 17503980
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of Prolonged Exposure Therapy, Sertraline Hydrochloride, and Their Combination Among Combat Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial.
    Rauch SAM, Kim HM, Powell C, Tuerk PW, Simon NM, Acierno R, Allard CB, Norman SB, Venners MR, Rothbaum BO, Stein MB, Porter K, Martis B, King AP, Liberzon I, Phan KL, Hoge CW.
    JAMA Psychiatry; 2019 Feb 01; 76(2):117-126. PubMed ID: 30516797
    [Abstract] [Full Text] [Related]

  • 17. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
    Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ.
    J Clin Psychopharmacol; 2006 Jun 01; 26(3):259-67. PubMed ID: 16702890
    [Abstract] [Full Text] [Related]

  • 18. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT, Clary CM.
    Compr Psychiatry; 2003 Jun 01; 44(5):360-9. PubMed ID: 14505296
    [Abstract] [Full Text] [Related]

  • 19. Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders?
    Labbate LA, Sonne SC, Randal CL, Anton RF, Brady KT.
    Compr Psychiatry; 2004 Jun 01; 45(4):304-10. PubMed ID: 15224273
    [Abstract] [Full Text] [Related]

  • 20. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo.
    Tucker P, Potter-Kimball R, Wyatt DB, Parker DE, Burgin C, Jones DE, Masters BK.
    Psychopharmacol Bull; 2003 Jun 01; 37(3):135-49. PubMed ID: 14608246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.